Commodore Capital LP
Commodore Capital LP is a hedge fund and financial investment management firm headquartered in New York, NY. Founded to provide investment solutions to high-net-worth individuals, institutions, and family offices, the firm has approximately 12 employees. Commodore Capital specializes in the healthcare and biopharmaceutical sectors, backing early-stage and innovative companies. The firm serves a global clientele, delivering both traditional and alternative investment strategies with a focus on long-term growth. Commodore Capital is known for a client-centric approach, providing comprehensive wealth management, customized financial planning, and disciplined investment advisory services.
Investment Strategy
Commodore Capital LP employs a disciplined investment approach focused on identifying long-term growth opportunities in the healthcare and biopharmaceutical sectors. The firm conducts thorough research to discover high-potential early-stage companies, with an emphasis on scientific breakthroughs, genetic medicines, and cellular therapies. By blending both traditional and alternative investments, Commodore offers a diversified portfolio that aims to mitigate risk and maximize returns. Commodore capitalizes on the current wave of innovation in biopharmaceuticals, partnering closely with companies aiming to deliver transformative therapies to patients worldwide.
Top Holdings
Equity Positions (33)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
M MRUS | MERUS N V | 13.09% | $185.4M | 3,525,000 | $30.24 | $52.60 | -$2.8M |
N NUVL | NUVALENT INC | 7.41% | $104.9M | 1,375,000 | $62.88 | $76.30 | -$26.6M |
X XENE | XENON PHARMACEUTICALS INC | 6.68% | $94.7M | 3,025,000 | $31.46 | $31.30 | +$16.7M |
E ELVN | ENLIVEN THERAPEUTICS INC | 6.64% | $94.1M | 4,692,809 | $19.93 | $20.06 | +$2.1M |
A AGIO | AGIOS PHARMACEUTICALS INC | 5.46% | $77.3M | 2,325,000 | $29.54 | $33.26 | +$13.3M |